BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khanam A, Chua JV, Kottilil S. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. Int J Mol Sci 2021;22:5497. [PMID: 34071064 DOI: 10.3390/ijms22115497] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
Number Citing Articles
1 Han H, Jin W, Li X. Mesenchymal stem cells-based therapy in liver diseases. Mol Biomed 2022;3:23. [DOI: 10.1186/s43556-022-00088-x] [Reference Citation Analysis]
2 Chen S, Liu X, Liu H, Lou J. The incidence rate, serological characteristics and cytokines profile of occult HBV infection in clinic.. [DOI: 10.21203/rs.3.rs-2171086/v1] [Reference Citation Analysis]
3 Xing T, Chen Q, Li A, Wang Q, Zhang Q, Xian J, Wang X. Role of miRNA-4804-3p in liver injury of chronic hepatitis B through inhibit chemerin/chemokine-like receptor 1 mediated NF-κB signal pathway.. [DOI: 10.21203/rs.3.rs-1943262/v1] [Reference Citation Analysis]
4 Xiang X, Wu Y, Lv XQ, Xu RQ, Liu Y, Pan SH, He M, Lai GQ. Hepatitis B Virus Infection Promotes M2 Polarization of Macrophages by Upregulating the Expression of B7x In Vivo and In Vitro. Viral Immunol 2022. [PMID: 36099202 DOI: 10.1089/vim.2022.0029] [Reference Citation Analysis]
5 Zhang Z, Lu W, Huang D, Zhou X, Ding R, Li X, Wang Y, Lin W, Zeng D, Feng Y. Capabilities of hepatitis B surface antigen are divergent from hepatitis B virus DNA in delimiting natural history phases of chronic hepatitis B virus infection. Front Immunol 2022;13:944097. [DOI: 10.3389/fimmu.2022.944097] [Reference Citation Analysis]
6 Gherlan GS. Occult hepatitis B — the result of the host immune response interaction with different genomic expressions of the virus. World J Clin Cases 2022; 10(17): 5518-5530 [DOI: 10.12998/wjcc.v10.i17.5518] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Zhao T, Qi J, Liu T, Wu H, Zhu Q. N6-Methyladenosine Modification Participates in the Progression of Hepatitis B Virus-Related Liver Fibrosis by Regulating Immune Cell Infiltration. Front Med (Lausanne) 2022;9:821710. [PMID: 35308519 DOI: 10.3389/fmed.2022.821710] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wang L, Fan Y. Current Advances of Innate and Adaptive Immunity in Acute-on-Chronic Hepatitis B Liver Failure. Infectious Diseases & Immunity 2022;2:113-121. [DOI: 10.1097/id9.0000000000000051] [Reference Citation Analysis]
9 Elbrolosy AM, Elabd NS, ElGedawy GA, Abozeid M, Abdelkreem M, Montaser B, Eed EM, Elhamouly MS. Toll- like receptor 2 polymorphism and IL-6 profile in relation to disease progression in chronic HBV infection: a case control study in Egyptian patients. Clin Exp Med 2022. [PMID: 35119591 DOI: 10.1007/s10238-022-00792-6] [Reference Citation Analysis]
10 Liu C, Shih YF, Liu CJ. Immunopathogenesis of Acute Flare of Chronic Hepatitis B: With Emphasis on the Role of Cytokines and Chemokines. Int J Mol Sci 2022;23:1407. [PMID: 35163330 DOI: 10.3390/ijms23031407] [Reference Citation Analysis]
11 Naghib M, Kariminik A, Kazemi Arababadi M. TLR2, as a Pathogen Recognition Receptor, Plays Critical Roles in Hepatitis B Outcome. Viral Immunol 2022. [PMID: 35020525 DOI: 10.1089/vim.2021.0141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]